HERON THERAPEUTICS INC (HRTX:NASDAQ)
$0.8917 -0.0181 (-1.9894%)
Analysed HERON THERAPEUTICS INC (HRTX:NASDAQ) News Sources
electroCore, Inc. (ECOR) Reports Q1 Loss, Beats Revenue Estimates
06-05-2026
yahoo.com
Ironwood Pharmaceuticals (IRWD) Tops Q1 Earnings and Revenue Estimates
07-05-2026
yahoo.com
Heron Therapeutics Announces First Quarter 2026 Financial Results and Reaffirms Guidance
11-05-2026
yahoo.com
Heron Therapeutics (HRTX) Reports Q1 Loss, Lags Revenue Estimates
11-05-2026
yahoo.com
Heron Therapeutics (HRTX) Reports Q1 Earnings: What Key Metrics Have to Say
11-05-2026
yahoo.com
Acute Care Revenue Growth Helps Heron (HRTX) Reaffirm 2026 Guidance Despite Q1 Sales Decline
11-05-2026
advfn.com
Heron Therapeutics Q1 Earnings Call Highlights
11-05-2026
marketbeat.com
Heron Therapeutics, Inc. Q1 2026 Earnings Call Summary
11-05-2026
moby.co
Heron Therapeutics Inc (HRTX) Q1 2026 Earnings Call Highlights: Resilient Growth Amidst Challenges
12-05-2026
yahoo.com
Why Heron Therapeutics, Inc. (HRTX) Price Target Was Reduced to $4 at H.C. Wainwright?
19-05-2026
yahoo.com
What is the current price of HERON THERAPEUTICS INC (HRTX:NASDAQ)?
The current price of HERON THERAPEUTICS INC (HRTX:NASDAQ) is $0.8917.
HERON THERAPEUTICS INC (HRTX:NASDAQ) absolute price change since previous trading day?
The absolute price change of HERON THERAPEUTICS INC (HRTX:NASDAQ) since the previous trading day is $-0.0181.
HERON THERAPEUTICS INC (HRTX:NASDAQ) percentage price change since previous trading day?
The percentage price change of HERON THERAPEUTICS INC (HRTX:NASDAQ) since the previous trading day is -1.9894%.
What is the most recent average sentiment score for HERON THERAPEUTICS INC (HRTX:NASDAQ)?
The most recent average sentiment score for HERON THERAPEUTICS INC (HRTX:NASDAQ) is 62 out of 100.
What is the most recent average sentiment for HERON THERAPEUTICS INC (HRTX:NASDAQ)?
The most recent sentiment for HERON THERAPEUTICS INC (HRTX:NASDAQ) is .
SEC-8K** Filing Available For HERON THERAPEUTICS INC (HRTX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.